
Results
26
Most Popular Stocks on the market
26 companies
Celon Pharma
Market Cap: zł1.1b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.
CLN
zł20.70
7D
-0.5%
1Y
-12.5%
Selvita
Market Cap: zł611.2m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł33.30
7D
4.7%
1Y
-4.3%
Ryvu Therapeutics
Market Cap: zł523.7m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł22.65
7D
-3.0%
1Y
-30.6%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł497.5m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł78.30
7D
0.4%
1Y
115.1%
Bioceltix
Market Cap: zł403.3m
Engages in the development of stem cell-based biopharmaceuticals for veterinary use.
BCX
zł81.90
7D
-2.2%
1Y
-28.8%
BIOTON
Market Cap: zł372.7m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł4.34
7D
1.2%
1Y
5.1%
Syn2bio
Market Cap: zł288.1m
A biotechnology company, engages in the research and commercialization of Cardiac Marker, a radiopharmaceutical for diagnostic testing of heart disease in the field of myocardial perfusion.
S2B
zł33.00
7D
14.4%
1Y
n/a
Synthaverse
Market Cap: zł212.0m
A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.
SVE
zł3.00
7D
-4.9%
1Y
-46.8%
Mabion
Market Cap: zł119.9m
A biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.
MAB
zł7.42
7D
-3.6%
1Y
-26.5%
Molecure
Market Cap: zł110.0m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.34
7D
1.1%
1Y
-36.0%
NanoGroup
Market Cap: zł101.0m
Operates as a biotechnology company in Poland.
NNG
zł2.37
7D
-1.3%
1Y
-23.5%
Genomtec
Market Cap: zł91.7m
Researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.
GMT
zł6.09
7D
-4.2%
1Y
-16.0%
Poltreg
Market Cap: zł90.9m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł19.50
7D
12.4%
1Y
-45.5%
HyEnergy
Market Cap: zł77.9m
Provides genetic diagnostic solutions in Poland.
HEN
zł2.32
7D
0%
1Y
-34.6%
Urteste
Market Cap: zł62.3m
Engages in the research and development of diagnostic tests for cancers.
URT
zł44.20
7D
4.2%
1Y
-46.1%
Read-Gene
Market Cap: zł62.3m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł5.28
7D
3.9%
1Y
22.8%
Biogened
Market Cap: zł44.5m
Produces and sells cosmetics and toiletries in Poland.
BGD
zł18.10
7D
-7.2%
1Y
-40.8%
Medicofarma Biotech
Market Cap: zł33.2m
Engages in the research and development of medicines, medicinal products, and biotechnology products in Poland.
MDB
zł0.49
7D
16.2%
1Y
84.2%
Genomed Spólka Akcyjna
Market Cap: zł31.7m
Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł24.00
7D
-5.5%
1Y
0%
Pure Biologics
Market Cap: zł23.5m
A biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use.
PUR
zł1.92
7D
-20.3%
1Y
-77.2%
genXone
Market Cap: zł19.8m
Operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally.
GX1
zł6.00
7D
0%
1Y
-3.8%
Stem Cells Spin
Market Cap: zł18.2m
Operates as a biotechnology company in Poland.
SCS
zł0.44
7D
10.0%
1Y
134.0%
Green Zebras Spolka Akcyjna
Market Cap: zł12.2m
Produces and sells herbal extracts focusing on Polish herbs and adaptogenic plants, mushrooms, fruits, and spices in Poland.
GRZ
zł7.70
7D
2.7%
1Y
-16.8%
Cannabis Poland
Market Cap: zł8.9m
Operates in the medical cannabis industry in Poland.
CBD
zł0.18
7D
-1.6%
1Y
-46.3%
Tecnovatica
Market Cap: zł7.9m
Engages in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets.
TEC
zł0.74
7D
13.9%
1Y
67.7%
Labocanna
Market Cap: zł4.4m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.21
7D
0.5%
1Y
-36.9%